Clinical trial
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients…
NCT00233935 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00233935 |
|---|---|
| Title | Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus |
| Official title | Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Barrett Esophagus |
| Intervention type | Drug, Other |
| Interventions | placebo, defined green tea catechin extract |
| Enrollment | 55 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Oct 6, 2005 |
| Last update posted | Sep 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: